SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine

Starting in December 2019, the current pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confronts the world with an unprecedented challenge. With no vaccine or drug being cur...

Source: Radiation Oncology - July 9, 2020 Category: Cancer & Oncology Authors: Sebastian Marschner, Stefanie Corradini, Josefine Rauch, Richard Zacharias, Ana Sujic, Julia Mayerle, Raluca Petru, B éatrice Grabein, Oliver T. Keppler, Edwin Boelke, Claus Belka and Maximilian Niyazi Tags: Research Source Type: research